
Providence Therapeutics
@providencethera
A clinical-stage #mRNA platform company developing #vaccines for #cancers and #InfectiousDiseases that pose public health risks
ID: 1641510108487114766
https://providencetherapeutics.com/ 30-03-2023 18:38:35
16 Tweet
80 Followers
219 Following




Happy National #Immunization Awareness Week! We're proud to support this campaign led by Immunize Canada & Cdn Public Health Assoc. highlighting the importance of routine immunizations to protect the Canadian population against vaccine-preventable diseases. #NIAW2023 #VaccinesWork #GetImmunized


Our CFO, Judyanna Yu, CPA, CA, and President & CTO, Robert Georgantas III, Ph.D., are attending Biotechnology Innovation Organization's BIO International Convention in Boston from June 5-8. Please reach out if you’d like to meet us there: bit.ly/41ZaCD0 #BIO2023



Our President & Chief Technology Officer, Robert Georgantas III, Ph.D., is participating in BioProcess Online upcoming panel to discuss the therapeutic #vaccine revolution and overcoming development and manufacturing challenges. Register for the panel here: bit.ly/3IqoQFj


A new paper in Scientific Reports, an open-access part of the Nature Portfolio, details the results of Providence's Phase 1 study of its mRNA-based COVID-19 vaccine candidate, the first clinical study to demonstrate encouraging data on Providence's mRNA platform: nature.com/articles/s4159…


Our Chief Financial Officer, Judyanna Yu, CPA, CA, and President & Chief Technology Officer, Robert Georgantas III, Ph.D., look forward to meeting fellow industry leaders at the Biotechnology Innovation Organization Convention. Reach out if you would like to meet us there: bit.ly/41ZaCD0 #BIO2023


We are thrilled to announce our partnership with the University Health Network to develop mRNA-based vaccines and therapeutics for those living with difficult-to-treat #cancers and #InfectiousDiseases. Learn more about our collaboration with the University Health Network here: bit.ly/43k8Mxk


Our Chief Financial Officer, Judyanna Yu, CPA, CA, and President & Chief Technology Officer, Robert Georgantas III, Ph.D., are enjoying connecting with industry leaders at the Biotechnology Innovation Organization Convention. Reach out if you would like to meet: bit.ly/41ZaCD0 #BIO2023


Our Chief Science Officer, Natalia Martin Orozco, Ph.D., will present at the Mexican Society of Immunology's 25th National Congress in Santiago de Querétaro, Mexico on Wednesday, June 7. Learn more here: bit.ly/426FKQb Sociedad Mexicana de Inmunología (SMI)


We're proud to be a gold sponsor of the Western Canada RNA Conference, RiboWest 2023, which brings together #RNA scientists from across #Canada and the northwestern United States. Our team will present on June 26 at 2:15 p.m. PT at University of Northern British Columbia (UNBC). Learn more here: fal.cn/3zlZK



Our President & CTO, Robert Georgantas III, Ph.D., was featured in a Drug Discovery News article highlighting the advantages of mRNA-based vaccines and our pipeline of vaccines in development for aggressive #cancers and #InfectiousDiseases. Read more here: fal.cn/3AkJ2